App aims to catch Quality-of-Life drops early in head and neck cancer survivors

NCT ID NCT05315570

Completed Knowledge-focused Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed trial tested a mobile app and web platform (BD4QoL) to monitor quality of life in 410 head and neck cancer survivors after curative treatment. The goal was to see if the platform could reduce or catch early declines in quality of life compared to standard follow-up. Participants used a smartphone app to report symptoms and complete questionnaires, while doctors tracked their data through a separate tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BD4QoL platform (mobile app and web tool for patient monitoring and quality of life questionnaires)
What this could lead to: If successful, this approach could help doctors detect and address quality-of-life declines earlier in head and neck cancer survivors, improving their well-being during follow-up.
What could go wrong: This is a completed study focused on monitoring, not a new treatment. The platform may not significantly reduce quality-of-life deterioration compared to standard care, and results may not apply to all cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms head and neck squamous cell carcinoma salivary gland cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER QUALITY OF LIFE SURVIVORSHIP

Contacts and locations

Locations

Fondazione Casa Sollievo della Sofferenza

San Giovanni Rotondo, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, Italy
University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.